Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 11 December 2008, doi:10.1136/bmj.a2509
Cite this as: BMJ 2008;337:a2509
Beverley A Lawton, director1, Sally B Rose, research fellow1, C Raina Elley, senior lecturer 2, Anthony C Dowell, professor3, Anna Fenton, endocrinologist4, Simon A Moyes, biostatistician2
1 Womens Health Research Centre, Department of Primary Health Care and General Practice, PO Box 7343, University of Otago, Wellington, New Zealand, 2 Department of General Practice and Primary Health Care, School of Population Health, University of Auckland, Private Bag 92019, Auckland, New Zealand, 3 Department of Primary Health Care and General Practice, PO Box 7343, University of Otago, Wellington, New Zealand, 4 Christchurch Womens Hospital, Christchurch, New Zealand
Correspondence to: B Lawton Bev.Lawton{at}otago.ac.nz
Design Randomised controlled trial.
Setting 17 primary care practices in Wellington, New Zealand
Participants 1089 women aged 40-74 not undertaking 30 minutes of moderate intensity physical activity on at least five days of the week
Intervention Brief physical activity intervention led by nurse with six month follow-up visit and monthly telephone support over nine months.
Main outcome measure Physical activity assessed at baseline and 12 and 24 months. Secondary outcomes were quality of life (SF-36), weight, waist circumference, blood pressure, concentrations of fasting serum lipids, glycated haemoglobin (HbA1c), glucose, insulin, and physical fitness.
Results Mean age was 58.9 (SD 7) years. Trial retention rates were 93% and 89% at 12 and 24 months, respectively. At baseline, 10% of intervention participants and 11% of control participants were achieving 150 minutes of at least moderate intensity physical activity a week. At 12 months rates increased to 43% and 30% and at 24 months to 39.3% and 32.8% (P<0.001), respectively. SF-36 physical functioning (P=0.03) and mental health (P<0.05) scores improved more in intervention compared with control participants, but role physical scores were significantly lower (P<0.01). There were no significant differences in clinical outcomes. More falls (P<0.001) and injuries (P=0.03) were recorded in the intervention group.
Conclusions This programme of exercise on prescription increased physical activity and quality of life over two years, although falls and injuries also increased. This finding supports the use of exercise on prescription programmes as part of population strategies to reduce physical inactivity.
Trial registration Australian New Zealand Clinical Trials Registry (ANZCTR) ANZCTRN012605000490673.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses